- The fall of Theranos, the much-hyped diagnostics company looking to revolutionize the field of blood testing, has been making headlines. This is a closer look at what exactly went wrong with Theranos and its charismatic founder, Elizabeth Holmes, following up on the heels of a detailed investigation published by the Wall Street Journal. Once the subject of glowing profiles that sounded like every Silicon Valley cliché come to life (her habit of drinking green smoothies containing kale and her fluency at Mandarin among the highlights), Holmes found herself going from being America's richest self-made woman (as per Forbes) to having her estimated net worth revised to zero. As it stands, she is now banned from participating in the blood-testing industry for two years and the company is in very deep waters.
- Making the point that promising scientific discoveries do not necessarily translate to blockbuster drugs, Science looks at six molecules - nitric oxide, hydrogen sulfide, leptin, ghrelin, myostatin and sirtuins - where the biology has turned out to be far more complex than the hype would lead us to believe.
- Here's a profile of Mitra Biotech, an Indian startup with a pioneering personalized medicine model that oncologists can use to tailor therapeutic regimens for individual patients.
- The newly-announced Chan-Zuckerberg Initiative has dedicated $3 billion to preventing, curing and eliminating disease by the turn of the century.
- And in sadly unsurprising news, the patent battle around the revolutionary CRISPR-Cas9 gene editing techniques gets uglier and more complicated.
Monday, September 26, 2016
Here are links to some interesting stories around the web: